CASSADY REMY PA
Prescription History 1730726621
Physician Assistant in Columbus, OH
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CASSADY REMY PA, an active Physician Assistant specialist practicing in Columbus, OH. Our medical registry currently tracks 18 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 445 documented patient claims. Among these therapy options, the most frequently utilized medication is Valacyclovir, which accounts for 64 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other OH PrescribersVs. OH Avg |
|---|---|---|---|
| ValacyclovirValacyclovir Hcl | 64 | $46.76 | ▲ More than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2023, this provider wrote 64 Medicare prescriptions for Valacyclovir, about 3.2 times the volume of the typical Ohio prescriber of this medication (20). Medicare paid an average of $46.76 per fill, versus $45.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 88 30-Day Fills standardized to 30-day supplies 2,640 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 56 | $30.20▼ below OH avg | ▲ More than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 56 Medicare prescriptions for Hydroxyurea, about 1.6 times the volume of the typical Ohio prescriber of this medication (36). Medicare paid an average of $30.20 per fill, versus $38.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 80.2 30-Day Fills standardized to 30-day supplies 2,367 Days of Medication total across all patients in 2023 | |||
| Imatinib Mesylate | 45 | $3,711.92 | ▲ More than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 45 Medicare prescriptions for Imatinib Mesylate, about 2 times the volume of the typical Ohio prescriber of this medication (22). Medicare paid an average of $3,711.92 per fill, versus $2,905.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,350 Days of Medication total across all patients in 2023 | |||
| JakafiRuxolitinib Phosphate | 42 | $18,115.46 | ▲ More than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 42 Medicare prescriptions for Jakafi, about 1.7 times the volume of the typical Ohio prescriber of this medication (25). Medicare paid an average of $18,115.46 per fill, versus $16,386.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50 30-Day Fills standardized to 30-day supplies 1,477 Days of Medication total across all patients in 2023 | |||
| Levofloxacin | 30 | $32.05 | ≈ Typical |
About Levofloxacin: This medication is used to treat a variety of bacterial infections. Show more ▾ Levofloxacin belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. Levofloxacin injection is used if you cannot take the medication by mouth. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2023, this provider wrote 30 Medicare prescriptions for Levofloxacin, about 1.2 times the volume of the typical Ohio prescriber of this medication (26). Medicare paid an average of $32.05 per fill, versus $9.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2023 | |||
| VenclextaVenetoclax | 26 | $6,199.92▼ below OH avg | ≈ Typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. In 2023, this provider wrote 26 Medicare prescriptions for Venclexta, about the same volume as the typical Ohio prescriber of this medication (25). Medicare paid an average of $6,199.92 per fill, versus $9,374.01 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 26 30-Day Fills standardized to 30-day supplies 641 Days of Medication total across all patients in 2023 | |||
| Fluconazole | 22 | $60.99 | ≈ Typical |
About Fluconazole: Fluconazole is used to treat vaginal yeast infections. Show more ▾ It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals. Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. In 2023, this provider wrote 22 Medicare prescriptions for Fluconazole, about the same volume as the typical Ohio prescriber of this medication (22). Medicare paid an average of $60.99 per fill, versus $12.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 688 Days of Medication total across all patients in 2023 | |||
| SprycelDasatinib | 21 | $7,490.26▼ below OH avg | ≈ Typical |
About Sprycel: This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. In 2023, this provider wrote 21 Medicare prescriptions for Sprycel, about 1.2 times the volume of the typical Ohio prescriber of this medication (18). Medicare paid an average of $7,490.26 per fill, versus $13,480.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $11.15 | ▼ Less than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 19 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 68% of the volume of the typical Ohio prescriber of this medication (28). Medicare paid an average of $11.15 per fill, versus $5.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21.7 30-Day Fills standardized to 30-day supplies 619 Days of Medication total across all patients in 2023 | |||
| ScemblixAsciminib Hydrochloride | 18 | $20,039.81 | – No State Data |
About Scemblix: Asciminib is used to treat a certain type of cancer (chronic myeloid leukemia-CML). Show more ▾ Asciminib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 18 Medicare prescriptions for Scemblix. Medicare paid an average of $20,039.81 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $20,039.81 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 16 | $8.74▼ below OH avg | ▼ Less than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 16 Medicare prescriptions for Allopurinol, about a third of the volume of the typical Ohio prescriber of this medication (55). Medicare paid an average of $8.74 per fill, versus $14.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2023 | |||
| PegasysPeginterferon Alfa-2a | 15 | $5,384.49 | ≈ Typical |
About Pegasys: Peginterferon alfa-2a is used alone or in combination with other medications to treat chronic hepatitis B and chronic hepatitis C, viral infections of the liver. Show more ▾ It works by decreasing the amount of hepatitis virus in the body and helps your body's natural defense (immune system) fight the infection. Chronic hepatitis infection can lead to serious liver damage (cirrhosis) and liver cancer. It is not known if peginterferon can cure hepatitis B or hepatitis C infections or can prevent you from passing the virus to others. Practice safer sex (such as the use of latex condoms) to lower the risk of passing the virus to others. In 2023, this provider wrote 15 Medicare prescriptions for Pegasys, about the same volume as the typical Ohio prescriber of this medication (15). Medicare paid an average of $5,384.49 per fill, versus $4,528.97 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18.6 30-Day Fills standardized to 30-day supplies 532 Days of Medication total across all patients in 2023 | |||
| Prednisone | 13 | $5.16▼ below OH avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 13 Medicare prescriptions for Prednisone, about a quarter of the volume of the typical Ohio prescriber of this medication (51). Medicare paid an average of $5.16 per fill, versus $5.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 13 30-Day Fills standardized to 30-day supplies 312 Days of Medication total across all patients in 2023 | |||
| IclusigPonatinib Hcl | 13 | $20,918.91▼ below OH avg | ≈ Typical |
About Iclusig: Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 13 Medicare prescriptions for Iclusig, about the same volume as the typical Ohio prescriber of this medication (12). Medicare paid an average of $20,918.91 per fill, versus $25,132.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| InqoviDecitabine/Cedazuridine | 12 | $9,086.15 | ▼ Less than typical |
About Inqovi: This medication contains 2 ingredients: decitabine and cedazuridine. Show more ▾ It is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells. People with MDS may have problems such as infections, anemia, and easy bleeding/bruising. Decitabine is thought to work by helping your bone marrow make normal blood cells. Decitabine also slows or stops the growth of abnormal blood cells that grow too fast and do not work properly. Cedazuridine helps decitabine work better by helping to prevent its breakdown in your body. In 2023, this provider wrote 12 Medicare prescriptions for Inqovi, about 67% of the volume of the typical Ohio prescriber of this medication (18). Medicare paid an average of $9,086.15 per fill, versus $8,474.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 11 | $25,614.46 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 11 Medicare prescriptions for Revlimid, about a quarter of the volume of the typical Ohio prescriber of this medication (46). Medicare paid an average of $25,614.46 per fill, versus $18,306.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
| Pantoprazole Sodium | 11 | $13.73▼ below OH avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2023, this provider wrote 11 Medicare prescriptions for Pantoprazole Sodium, about 13% of the volume of the typical Ohio prescriber of this medication (86). Medicare paid an average of $13.73 per fill, versus $15.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 21 30-Day Fills standardized to 30-day supplies 614 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 11 | $897.45 | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 11 Medicare prescriptions for Xarelto, about a quarter of the volume of the typical Ohio prescriber of this medication (47). Medicare paid an average of $897.45 per fill, versus $861.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for CASSADY REMY PA is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Columbus, OH practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among OH prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
